Of note, the increased predisposition to one hematopoietic lineage over the other is not exclusive, and variants in genes commonly associated with CH (e.g., DNMT3A and TET2) appear to be associated with both myeloid and lymphoid neoplasms (von Beck et al., 2023). This evidence concerns the gene TET2 and cyclic hematopoiesis.